Shoulder Innovations, a medical technology company focused on shoulder surgical care, reported a 33% increase in net revenue to $11.0 million in Q2 2025.
The company achieved a gross margin of 76.2% and sold 1,503 implant systems, a 34% increase year-over-year.
Recent milestones include closing a $40 million convertible notes financing and completing an IPO raising $75 million.
Revenue Growth
Net revenue increased by 33% to $11.0 million in Q2 2025.
Strategic Financing
Closed a $40 million convertible notes financing and raised $75 million in an IPO.
Market Expansion
Expanded the surgeon customer base by nearly 50% year-over-year in Q2 2025.
- Shoulder Innovations' operational progress and financial results reflect the market's adoption of its advanced implant systems for shoulder arthroplasty.
- The company's successful convertible notes financing and IPO position it well to scale investments and execute growth strategies.
With a strong Q2 performance and successful financing activities, Shoulder Innovations is poised to continue leading in the shoulder surgical care market.